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Background The association between respiratory infection and risk of heart attacks
and strokes is well established. However, less evidence exists
for an association between respiratory infection and venous thrombo-
embolism (VTE). In this article, we describe the associations between
respiratory infection and VTE.
Methods All cases aged 518 years of first-time diagnosis of deep-vein
thrombosis (DVT) or pulmonary embolism (PE) were identified to-
gether with single-matched controls from a primary care general
practice database. In addition to the matching characteristics, in-
formation was collected on other potentially important confounding
factors.
Results There were 457/11557 (4.0%) DVT cases with respiratory infection
in the year before the index date (73 in the preceding month)
compared with 262/11557 (2.3%) controls (24 in the preceding
month). There was an increased risk of DVT in the month following
infection [adjusted odds ratio (OR)¼2.64, 95% confidence interval
(95% CI) 1.62–4.29] which persisted up to a year. There were 180/
5162 (3.5%) PE cases with respiratory infection in the year before
the index date compared with 94/5162 (1.8%) controls excluding
those in the preceding month to avoid the possible misdiagnosis of
early PE. There was an increased risk of PE in the 3 months fol-
lowing infection (adjusted OR¼2.50, 95% CI 1.33–4.72) which may
have persisted up to a year.
Conclusions There are strong associations between recent respiratory infection
and VTE. There should be less distinction between venous and
arterial events in decisions about preventing or aborting infections,
especially in high-risk patients.
Keywords Deep-vein thrombosis, pulmonary embolism, respiratory tract infec-
tion, case–control studies, venous thromoembolism
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Several large-scale epidemiological studies have con-
sistently demonstrated associations between respira-
tory infection and the risk of myocardial infarction
(MI) or stroke within the next month or so, the high-
est risk occurring within the first few days and then
gradually declining until there is little or no risk at a
month.
1–5 Since infection influences processes likely to
lead to thrombosis, the association between respira-
tory infection and vascular events may be causal.
6,7
However, there has until recently been little epi-
demiological work from large-scale, population-based
studies on the association of infection with venous
thromboembolism (VTE). In 2006, Smeeth et al.
8 re-
ported on the risk of deep-vein thrombosis (DVT) and
pulmonary embolism (PE) after acute infection, using
the self-controlled case–series method, carried out
through the UK’s Health Improvement Network data-
base. They pointed out that pleuritic symptoms early
on could have been due to either respiratory infec-
tion or PE. However, the risk of DVT was increased
up to 6 months following respiratory infection with
an incidence ratio of 1.91 [95% confidence interval
(95% CI) 1.49–2.44] in the first 2 weeks. The risks
of both DVT and PE were also raised following
urinary tract infection.
It is important to confirm or refute these findings in
a different population and by a different method.
Accordingly, we now report results on infection and
VTE in the IMS Disease Analyser-Mediplus (IMS)
database using a different design and analytical
method and on hitherto less well-known risk factors
for VTE.
Methods
The IMS database is a primary care database used
widely in epidemiological research, recording contacts
of some 3.5 million patients with  670 general prac-
titioners (GPs). In order to be included in the data-
base, GPs need to meet a minimum quality score
based on a number of pre-specified criteria e.g. the
percentage of registered patients with completed
demographic information.
Cases and controls
Using the READ coding system, cases of DVT or PE
were selected from those in whom one or other was a
first-time diagnosis.
9,10 In order to avoid the risk of
retrospective recording of events in patients joining
the practice only recently and to allow a sufficient
period for exposures and other risk factors to have
been recorded, patients had to be registered on the
IMS database for at least 2 years prior to the date
of diagnosis. If the patient was admitted to hospital
as an emergency, a summary is sent to the GP shortly
after the patient’s discharge or death, which includes
date of onset. In addition to the date of diagnosis,
there was a requirement for cases to have information
on their year of birth, gender and practice, which
were the matching criteria for selecting controls. The
only restriction on the age of cases was that they
needed to be aged 518 years at the date of the
index event.
In order to match on calendar time (to allow for
seasonal variation), all potential controls have been
registered on the IMS database for at least 2 years
on the day of the index DVT or PE of the case, and
to have no previous recorded diagnosis of the corres-
ponding outcome by that date. A single control for
each case was selected at random from among all
potential controls before the exposure status or his-
tory of other risk factors was known.
Measurement of risk factors
The definition for respiratory infection was estab-
lished based on the READ codes using terms which
included reference to diagnoses and symptoms such
as ‘acute laryngitis’, ‘acute bronchitis’, ‘pneumonia’
and ‘productive cough’. In order to exclude mild
respiratory infections, we did not include terms for
minor symptoms. Based on this definition, data for
the most recent GP visit for respiratory infection
over the year preceding the index date were extracted.
To ensure the correct order of the timing of infection
and outcome, any episode of respiratory infection
recorded on the same day as the index date was
excluded. In addition, information on GP visits for
urinary tract infection over the preceding year was
extracted.
In order to adjust for possible confounding and to
identify the most important contributors to the under-
lying risk of participants, details of other possible risk
factors recorded prior to the index date were also col-
lected. Pre-defined criteria also based on the READ
coding system were used to identify any history of
hypertension, hyperlipidaemia, diabetes, coronary
heart disease among first-degree relatives, peripheral
vascular disease, angina, MI, stroke and chronic ob-
structive pulmonary disease. Data on Factor V Leiden
and prothrombin gene mutations were also collected
but these were identified only in two individuals (both
with Factor V Leiden) and so were not considered
in the analysis. Pregnancy within the last 7 months,
giving birth within the last 3 months, and cancer,
major surgery and vaccinations against influenza
and pneumococcal disease, each within the last year,
were also recorded. In addition, smoking status,
weight, height and body mass index (BMI) were
taken from the most recent recorded entry on the
database. Categorical risk factors that were not re-
corded for an individual while registered on the IMS
database were assumed to be absent. Continuous
measures, such as weight, which were not recorded
were taken as missing.
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All individuals meeting the eligibility criteria on the
IMS database in the 15 years up to November 2006
were included in the analysis. It was anticipated that
in excess of 10000 newly recorded cases of DVT
would be included. Smeeth demonstrated an impact
of respiratory infection on DVT up to 26 weeks fol-
lowing infection, and our study was anticipated to
provide excellent power to detect small associations
even at low levels of respiratory infection during
this period. Thus a study of 10000 DVTs would
have well in excess of 95% power (at 5% significance)
to detect an odds ratio (OR) of 1.5 based on a preva-
lence of respiratory infection of 2% within the preced-
ing 26 weeks among controls.
In all analyses, cases of DVT and their controls were
analysed separately from cases of PE and their con-
trols. In order to exclude the possible misdiagnosis of
early PE as a respiratory infection, cases and controls
with infections recorded within the month preceding
the index date were excluded.
Conditional logistic regression was used to account
for the matched design of the study. Therefore all ORs
are adjusted for year of birth, gender, calendar time
(and therefore seasonal variation) and practice, the
last of which may to some extent allow for socio-
economic status and other confounding factors. In
addition, other recorded risk factors were included
in the two multivariable models if they were strong
independent predictors (P<0.01) of at least one of
the outcomes.
The timing of any respiratory infection was con-
sidered in the following categories: 1–4, 5–12, 13–26
and 27–52 weeks prior to the index date. A further
analysis looking 1–2 weeks prior to the index date
was conducted to compare results with the previous
Health Improvement Network study.
8 The unexposed
group are those with no infection in the previous
year. In order to consider the impact of the severity
of infection on the outcome, additional analyses cate-
gorized respiratory infections as (i) pneumonia or
(ii) other infections.
A limited number of pre-specified subgroup analyses
were undertaken to explore whether any associations
between respiratory infection and DVT or PE were
consistent across all levels of prior underlying risk of
these events or whether those at an already higher
risk had no additional risk from infection. Recent in-
fection was considered as 1–4 and 5–52 weeks before
the index date for DVTs, and 5–52 weeks for PEs, in
order to give reasonable numbers for testing inter-
actions. Patients were categorized into three groups
according to their underlying risk of DVT or PE. A
patient’s risk was determined from the coefficients
of the logistic model of risk factors related to each
outcome, but excluding respiratory infection.
Patients were then divided into approximate thirds
of risk so that each group contained a similar number
of patients. For both DVT and PE, the lowest risk
group comprised those patients with no recorded risk
factors, since this applied to 36% of individuals in the
DVT study and 34% in the PE study. Separate ORs for
the impact of respiratory infection on the outcome were
calculated for each risk group. The presence of effect
modification between respiratory infection and the
three risk groups was assessed by a test of interaction.
Since cases and controls were matched on age and
gender, it was not possible to assess the independent
associations of these factors on outcome and so these
were not included in categorization above. However,
the impacts of age and gender on the association be-
tween respiratory infection and outcome were assessed
using interaction tests.
The study was approved by the Independent
Scientific and Ethical Advisory Committee of the
IMS Disease Analyzer Mediplus Database and the
Ethics Committee of the London School of Hygiene
& Tropical Medicine.
Results
There were 11557 cases on the IMS database with a
first-time diagnosis of DVT who met the inclusion
criteria, of whom 42% were men (mean age 62 years)
and 58% women (mean age 63 years) (Table 1). There
were 5162 cases with a first-time diagnosis of PE,
of whom 42% were men (mean age 64 years) and
58% women (mean age 63 years). The recorded risk
factors, both familiar and those less well established,
were more prevalent among the cases for both DVTs
and PEs compared with the controls (Table 1).
In total, there were 457 (4.0%) DVT cases with re-
spiratory infection in the year before the index date
[73 (0.6%) in the preceding month] compared with
262 (2.3%) controls [24 (0.2%) in the preceding
month]. There was very strong evidence of an
increased risk of a DVT in the weeks following infec-
tion, which reduced over time but was still apparent
up to a year later (trend test across the different
time periods considered, P<0.0001) (Table 2). After
adjustment for other risk factors, the OR of DVT
within 4 weeks of an infection was 2.64 (95% CI
1.62–4.29) with an OR between 26 weeks to 1 year
of 1.53 (95% CI 1.17–1.99).
Of the 719 respiratory infections in the year before the
index date, the majority could be categorized under pro-
ductive cough (n¼398), acute laryngitis/tracheitis
(n¼174), pneumonia/influenza (n¼102) or acute
bronchitis (n¼19). For the DVT study, of the 97 infec-
tions in the first month, 28 were reported as pneumonia
and 69 as other infections. There was evidence that
more severe infection with pneumonia was associated
with increased risk of subsequent DVT (adjusted
OR¼10.55, 95% CI 2.46–45.34) although associations
were also seen with less severe infection (OR¼1.86,
95% CI 1.08–3.20). Further, of the 622 infections at be-
tween 1 month and 1 year, 74 were reported as pneu-
monia and 548 as other infections. The ORs for both
RESPIRATORY INFECTION AND RISK OF VTE 821Table 1 Baseline characteristics of cases and controls
DVT PE
Cases
(n¼11557)
Controls
(n¼11557)
Cases
(n¼5162)
Controls
(n¼5162)
Matching variables
Gender, n (%)
Male 4867 (42.1) 4867 (42.1) 2146 (41.6) 2146 (41.6)
Female 6690 (57.9) 6690 (57.9) 3016 (58.4) 3016 (58.4)
Age (years)
Mean (SD) 63 (17) 63 (17) 64 (17) 64 (17)
<40, n (%) 1441 (12.5) 1441 (12.5) 602 (11.7) 602 (11.7)
40–49, n (%) 1237 (10.7) 1237 (10.7) 503 (9.7) 503 (9.7)
50–59, n (%) 1745 (15.1) 1745 (15.1) 743 (14.4) 743 (14.4)
60–69, n (%) 2356 (20.4) 2356 (20.4) 1041 (20.2) 1041 (20.2)
70–79, n (%) 2733 (23.6) 2733 (23.6) 1314 (25.5) 1314 (25.5)
580, n (%) 2045 (17.7) 2045 (17.7) 959 (18.6) 959 (18.6)
Index month, n (%)
December–February 3054 (26.4) 3054 (26.4) 1470 (28.5) 1470 (28.5)
March–May 2943 (25.5) 2943 (25.5) 1248 (24.2) 1248 (24.2)
June–August 2839 (24.6) 2839 (24.6) 1206 (23.4) 1206 (23.4)
September–November 2721 (23.5) 2721 (23.5) 1238 (24.0) 1238 (24.0)
Other risk factors, n (%)
Hyperlipidaemia 668 (5.8) 590 (5.1) 304 (5.9) 227 (4.4)
Hypertension 2960 (25.6) 2545 (22.0) 1407 (27.3) 1189 (23.0)
Diabetes 906 (7.8) 591 (5.1) 350 (6.8) 274 (5.3)
Chronic obstructive pulmonary disease 467 (4.0) 267 (2.3) 256 (5.0) 121 (2.3)
Family history of coronary heart disease 1108 (9.6) 960 (8.3) 499 (9.7) 422 (8.2)
Angina 985 (8.5) 706 (6.1) 667 (12.9) 309 (6.0)
Peripheral vascular disease 292 (2.5) 162 (1.4) 107 (2.1) 70 (1.4)
Smoking status
Never
a 8228 (71.2) 8815 (76.3) 3588 (69.5) 3963 (76.8)
Ex-smoker 1677 (14.5) 1433 (12.4) 860 (16.7) 635 (12.3)
Current 1652 (14.3) 1309 (11.3) 714 (13.8) 564 (10.9)
Previous MI 331 (2.9) 234 (2.0) 294 (5.7) 107 (2.1)
Previous stroke 304 (2.6) 163 (1.4) 129 (2.5) 67 (1.3)
Pregnancy within past 7 months 246 (2.1) 69 (0.6) 103 (2.0) 18 (0.3)
Birth within past 3 months 133 (1.2) 20 (0.2) 104 (2.0) 8 (0.2)
Cancer within past year 1062 (9.2) 317 (2.7) 585 (11.3) 139 (2.7)
Major surgery within past year 2922 (25.3) 1355 (11.7) 1528 (29.6) 600 (11.6)
Influenza vaccination
b 3469 (30.0) 2771 (24.0) 1645 (31.9) 1385 (26.8)
Pneumococcal vaccination 450 (3.9) 390 (3.4) 231 (4.5) 199 (3.9)
Weight (kg)
Total n¼7694 n¼6835 n¼3403 n¼3064
Mean (SD) 79.2 (19.6) 73.3 (16.5) 78.5 (18.9) 72.9 (16.2)
(continued)
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justed OR¼1.95, 95% CI 1.13–3.36 and adjusted
OR¼1.44, 95% CI 1.19–1.75, respectively).
Further adjustment was made using the most recent
weight measurement. This was available for both
cases and controls in 43% of the matched sets, where-
as both height and BMI were available for cases and
controls in <10% of the matched sets. As expected,
weight was a risk factor for DVT (OR 1.26 per 10kg
increase, 95% CI 1.22–1.29) although this had little
impact on the relationship between respiratory infec-
tion and DVT.
There was a suggestion that the association between
recent infection and DVT might depend on underlying
prior risk (interaction P¼0.010) (Table 3). Whereas
there was a short-term (i.e. up to 4 weeks) increased
risk of DVT in all three risk strata, the longer-term
risk of DVT (i.e. 44 weeks) seemed to decrease in
those with a higher underlying prior risk but the OR
remained41. There was little evidence that the risk of
DVT from respiratory infection depended upon age or
gender (interaction P-values 0.12 and 0.84, respect-
ively). As expected, cases and controls had clearly
different underlying risks. Hence more controls than
cases were in the low-risk group, whereas there were
more cases than controls in the higher-risk group.
There were 180 (3.5%) PE cases with respiratory
infection in the year before the index date (excluding
the previous month) compared with 94 (1.8%) con-
trols. There was a similar association of respiratory
infection with PE as for DVT, with an increased
risk of a PE following infection which decreased over
time, but still with a suggestion that the risk was
raised a year after infection (trend test across the
different time periods considered, P¼0.001) (Table 2).
After adjustment for other risk factors, the OR of PE
between 5 and 12 weeks after an infection was 2.50
(95% CI 1.33–4.72), with an OR between 26 weeks to
1 year of 1.38 (95% CI 0.93–2.04).
For the PE study, of the 274 infections in the year
preceding the index date, 46 were reported as pneu-
monia and 228 as other infections. Infection with
pneumonia was associated with a higher OR of PE
although associations were also seen with less
severe infection (adjusted OR¼2.38, 95% CI 1.13–
4.99 and OR¼1.44, 95% CI 1.06–1.97, respectively).
Risk of PE from respiratory infection did not depend
upon underlying prior risk, age or gender (interaction
P-values 0.50, 0.16 and 0.84, respectively).
As for DVT, there was a strong association between
weight and risk of PE (OR¼1.23 per 10kg increase,
95% CI 1.18–1.29) although adjustment for weight
had no impact on the relationship between respiratory
infection and PE.
Urinary tract infection was less common than re-
spiratory infection and numbers were small. There
was weak evidence of an association with subsequent
DVT (trend test, P¼0.065) and no evidence of incre-
ased risk of PE following urinary tract infection
(trend test, P¼0.32).
Discussion
We omitted PE events occurring within the first
month after the onset of a respiratory infection and
therefore avoided most, if not all, the period during
which the pleuritic symptoms of infection and PE
Table 1 Continued
DVT PE
Cases
(n¼11557)
Controls
(n¼11557)
Cases
(n¼5162)
Controls
(n¼5162)
Respiratory tract infection (weeks), n (%)
1–4
c 73 (0.6) 24 (0.2) – –
5–12 86 (0.7) 54 (0.5) 47 (0.9) 16 (0.3)
13–26 115 (1.0) 78 (0.7) 46 (0.9) 29 (0.6)
27–52 183 (1.6) 106 (0.9) 87 (1.7) 49 (0.9)
None in previous year 11100 11295 4982 5068
Urinary tract infection (weeks), n (%)
1–4 13 (0.1) 11 (0.1) 6 (0.1) 5 (0.1)
5–12 29 (0.3) 14 (0.1) 9 (0.2) 15 (0.3)
13–26 35 (0.3) 27 (0.2) 19 (0.4) 14 (0.3)
27–52 69 (0.6) 49 (0.4) 28 (0.5) 20 (0.4)
None in previous year 11411 11456 5100 5108
aThese numbers include 11192 patients in the DVT dataset, and 4904 in the PE dataset with no definite smoking status recorded.
bThere were 49.6% of DVT cases and 42.4% of controls aged 570 years with a recorded influenza vaccination. There were 49.6% of
PE cases and 44.3% of controls aged 570 years with a recorded influenza vaccination.
cFor DVT: 39 cases and 14 controls in Weeks 1 and 2, and 34 cases and 10 controls in Weeks 3 and 4.
RESPIRATORY INFECTION AND RISK OF VTE 823might be confused with each other. Thus we conclude
that there probably is an increased risk following in-
fection for PE as well as for DVT and that this may be
related to the severity of the infection. Our results for
VTE following urinary infections are inconclusive,
mainly because of the relatively small number of urin-
ary infections occurring.
One previous study based on 494 medical out-
patients, compared with the same number of controls
who had already had an infection selected from other
patient groups, showed only a strong association be-
tween ‘infectious disease’ and DVT (P¼0.001)
although the results are difficult to interpret.
11
Another study was a secondary analysis among 866
acutely ill and immobilized hospitalized patients
taken from a randomized controlled trial of low mo-
lecular weight heparin for the prevention of VTE.
12
However, there has only been one other sufficiently
large community-based epidemiological study, which
used the Health Improvement Network general prac-
tice database, drawing patients and controls from the
same defined population.
8 Ours has used a different
general practice database and a different analytical
method with the advantage that we have been able
Table 2 Multivariable predictors of DVT and PE
a
Risk factor
DVT PE
OR (95% CI) P-value OR (95% CI) P-value
Respiratory infection (weeks)
1–4
b 2.64 (1.62–4.29) <0.0001
c – 0.001
c
5–12 1.56 (1.08–2.25) 2.50 (1.33–4.72)
13–26 1.39 (1.02–1.90) 1.36 (0.80–2.31)
26–52 1.53 (1.18–2.00) 1.38 (0.93–2.04)
None in previous year 1 1
Major surgery within past year 2.41 (2.23–2.61) <0.0001 3.03 (2.69–3.42) <0.0001
Cancer within past year 3.16 (2.75–3.63) <0.0001 4.25 (3.42–5.28) <0.0001
Influenza vaccination 1.35 (1.25–1.45) <0.0001 1.15 (1.03–1.29) 0.016
Pregnancy within past 7 months 3.6 (2.50–4.78) <0.0001 4.92 (2.66–9.10) <0.0001
Smoking status
Never 1 <0.0001 1 <0.0001
Ex-smoker 1.17 (1.08–1.28) 1.43 (1.24–1.64)
Current smoker 1.32 (1.20–1.44) 1.46 (1.26–1.69)
Birth within past 3 months 4.67 (2.74–7.96) <0.0001 16.74 (6.92–40.51) <0.0001
Previous stroke 1.83 (1.48–2.25) <0.0001 1.82 (1.30–2.57) 0.001
Diabetes 1.40 (1.24–1.57) <0.0001 1.06 (0.88–1.28) 0.55
Chronic obstructive pulmonary disease 1.53 (1.29–1.82) <0.0001 1.99 (1.55–2.55) <0.0001
Angina 1.21 (1.08–1.36) 0.001 1.97 (1.66–2.33) <0.0001
Peripheral vascular disease 1.45 (1.17–1.79) 0.001 1.24 (0.88–1.76) 0.22
Hypertension 1.13 (1.05–1.21) 0.001 1.17 (1.04–1.31) 0.007
MI 1.12 (0.92–1.36) 0.26 2.16 (1.66–2.80) <0.0001
Urinary tract infection (weeks)
1–4 1.10 (0.47–2.58) 0.065
c 0.99 (0.27–3.59) 0.32
c
5–12 2.28 (1.14–4.59) 0.49 (0.20–1.22)
13–26 1.09 (0.63–1.88) 0.93 (0.41–2.10)
26–52 1.15 (0.78–1.70) 1.08 (0.56–2.08)
None in previous year 1 1
aORs for binary variables are for presence vs absence of risk factor. Note model also adjusted for the matching factors of age, sex,
GP practice and index date (seasonality).
ORs adjusted for matching factors only: DVT 3.08, 1.61, 1.52 and 1.80 in the four time periods; PE 3.00, 1.66 and 1.82 in the three
time periods.
bFor DVT: Weeks 1 and 2 OR¼2.26 (95% CI 1.19–4.31), Weeks 3 and 4 OR¼3.19 (95% CI 1.51–6.73).
cTrend test across groups.
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factors for VTE as well as those that are well
recognized.
One concern with case–control studies is that of re-
sidual confounding where confounders have not been
accounted for adequately. However, our results are
largely consistent with the Smeeth study which used
the case–series method, thus virtually eliminating the
possibility of residual confounding.
8 Further, our
study matched on age, gender, seasonality and GP
practice, all potentially important confounders of the
association between respiratory infection and VTE.
Other important predictors of VTE were also adjusted
for in the analyses. Thus, residual confounding may
not be an important factor in interpreting our results.
There was a gradient of decreasing risk of VTE with
increasing time after infection, and we consider it un-
likely that further adjustment would explain this re-
lationship. Smeeth summarized plausible mechanisms
whereby infection might increase risk of arterial or
venous clinical events, including increased thrombotic
tendency, strengthening the case for at least consider-
ing causality, although some caution should be exer-
cised as causality is only one possible explanation of
the associations.
Consideration also needs to be given to the possible
role of intermediate factors in the association between
infection and VTE although these are unlikely to ex-
plain the strong associations seen. In particular,
although we were not able to collect reliable informa-
tion on physical activity following infection, we think
the majority of individuals would not reduce their
physical activity to the extent detailed in the NICE
guidelines.
13 The exception might be following
pneumonia and influenza but these only account for
 15% of the infections and it is unlikely that reduced
activity would account for the associations seen up to
a year. In addition, our analyses show strong associ-
ations up to a year of infections other than pneumo-
nia and influenza with VTE.
A further concern relates to the definition of respira-
tory infection used. We recognize mild infection is
unlikely to be associated with VTE and have been
careful to include terms which exclude minor symp-
toms of infection. Indeed our analyses indicate that
the associations are associated with severity of symp-
toms. The number of infections reported is lower than
expected and supports our view that we have cap-
tured the more severe infections. However, if less
severe infections have been included this is likely to
dilute any effect and underestimate the associations.
A link of infection with DVT for up to a year was
observed in our study, substantially longer than for
the association between respiratory infection and ar-
terial events. This continued association (up to
26 weeks) was also observed in the Smeeth study.
8
One explanation for this time period might be that
some respiratory infections trigger minor but entirely
subclinical VTE, which build up and result in a major
episode much later on. This pattern of high early risk
of VTE following exposure to a risk factor which
remains raised up to a year has also been seen in
women after surgery from a very large, prospective
cohort study.
14
Not all cases and controls had information available
on all risk factors, but the expected associations be-
tween these and DVT or PE support the general qual-
ity of the risk factor data. We were also able to assess
Table 3 Effect of respiratory infection within the preceding month on DVT and PE according to approximate third of risk
a
Third of risk
Infections
in period
prior to
index date
DVT PE
b
Cases (%) Controls (%) OR
c (95% CI) Cases (%) Controls (%) OR
c (95% CI)
First (no risk
factors)
1–4 weeks 11 (0.4) 9 (0.2) 2.06 (0.83–5.17) – – –
5–52 weeks 81 (2.7) 63 (1.2) 2.28 (1.60–3.25) 23 (2.0) 27 (1.2) 1.54 (0.85–2.78)
Total patients 3053 5230 1179 2289
Second 1–4 weeks 20 (0.6) 7 (0.2) 2.62 (1.07–6.40) – – –
5–52 weeks 104 (3.0) 81 (2.2) 1.45 (1.07–1.98) 47 (3.0) 40 (2.1) 1.40 (0.89–2.21)
Total patients 3483 3657 1554 1876
Third 1–4 weeks 42 (0.8) 8 (0.3) 2.76 (1.28–5.98) – – –
5–52 weeks 199 (4.0) 94 (3.5) 1.13 (0.87–1.47) 110 (4.5) 27 (2.7) 1.80 (1.13–2.86)
Total patients 5021 2670 2429 997
aBased on the models in Table 2 but excluding respiratory infection and factors unrelated to outcome: note the lowest third
contains all patients with no risk factor present. A patient will be in the middle or highest third depending on which risk factors
are present and also how many. For example, in the DVT study, patients with chronic obstructive pulmonary disease alone or
diabetes alone would both be in the middle third of risk because of the strength of the coefficients whereas any individual with
major surgery within the past year would be in the top third of risk because the coefficient for surgery was high.
bRespiratory infections within the month preceding the PE excluded.
cInteraction between infection and risk group: (i) DVT, P¼0.010, (ii) PE, P¼0.50.
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prior underlying risk. For DVT, the data suggest
raised ORs associated with respiratory infection at
all levels of risk particularly in the month following
the infection. The results also suggest an increased
risk of PE following infection irrespective of the under-
lying risk, although numbers are lower.
Our results, based on large numbers, contribute to
clarifying risk factors for VTE, findings on some of
which have hitherto been inconsistent. The associ-
ations for weight, recent surgery or cancer, pregnancy
and parturition were all as expected, suggesting that
the data on risk factors are reliable even if they are
not recorded for all those concerned. We found po-
tentially important associations with both DVT and
PE of two other risk factors over which there have
previously been uncertainties, i.e. for current smoking
and hypertension. Most of the manifestations of
arterial disease recorded in our study on heart attacks
were also associated with VTE, especially previous
stroke and also angina and peripheral vascular
disease.
4 MI was not associated with DVT, but there
was a strong association with PE.
Pomp et al.
15 have reported strong associations be-
tween current and former smoking with VTE: for
example OR 1.43 (95% CI 1.28–1.60) for current
smoking. There was also a graded risk according to
daily cigarette consumption, OR 1.23 (95% CI 1.00–
1.50) for 1–9 cigarettes a day and OR 1.64 (1.41–
1.90) for 520 cigarettes a day. The number of
pack-years was also strongly associated with risk of
VTE. Thus, it seems possible that smoking is related
to VTE. However, Ageno et al.
16 found no association
for smoking, nor did Rosengren et al.
17 in a study
primarily concerned with psychosocial factors, al-
though they reported a strong association with trea-
ted hypertension (OR 1.95, 95% CI 1.37–2.80). Ageno
also reported an increased risk associated with hyper-
tension. Sorensen et al.
18 have recently reported that
for patients with DVT, the relative risks for MI and
stroke in the first year subsequently were 1.60 (95%
CI 1.35–1.91) and 2.19 (95% CI 1.85–2.60), respect-
ively. Uncertainty exists as to the benefits of
influenza immunization for reducing cardiovascular
events.
5
In summary, there are more similarities in the epi-
demiology of VTE and arterial disease than have pre-
viously been recognized. Thus, it may be inappropriate
to distinguish rigidly between venous and arterial
events when considering the possible risks of an ex-
posure such as respiratory infection and monitoring
patients for these events. It is by no means standard
practice in the UK that patients with an acute respira-
tory infection should receive anti-thrombotic prophy-
laxis, but the possibility that they might benefit is one
of the important questions raised by our study, which
can only be settled by a randomized controlled trial.
Planning any prophylactic measures should probably
be considered in terms of thrombotic events as a
whole rather than for arterial and venous events
separately.
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KEY MESSAGES
  There is little previous epidemiological evidence on the association of respiratory infection with VTE.
  This study shows clear associations of respiratory infection with both DVT and PE for up to a year
following respiratory infection.
  Respiratory infection increases the risk of DVT within the next month and PE up to a year at all levels
of prior underlying risk.
  As well as more familiar risk factors such as obesity, the study also suggests that cigarette smoking
and hypertension are associated with VTE.
  Following respiratory infection, the risk of venous and arterial events should be considered jointly
rather than in separate categories, and prophylactic measures should be planned accordingly.
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